Peter Wolfe - 16 Dec 2022 Form 4 Insider Report for ZyVersa Therapeutics, Inc. (ZVSA)

Role: Chief Financial Officer
Signature: /s/ Peter Wolfe
Issuer symbol: ZVSA
Transactions as of: 16 Dec 2022
Net transactions value: +$8,644
Form type: 4
Filing time: 20 Dec 2022, 15:00:18 UTC
Previous filing: 13 Dec 2022
Next filing: 18 Jul 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZVSA	Common Stock	Award	$8,644	+3,000	+7.2%	$2.88^*	44,585	16 Dec 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.78 to $2.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.78 to $2.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.